HSCSX | VSCPX | HSCSX / VSCPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 14 years | - |
Gain YTD | 7.750 | 13.912 | 56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 244M | 152B | 0% |
Annual Yield % from dividends | 0.08 | 1.44 | 5% |
Returns for 1 year | 18.16 | 28.46 | 64% |
Returns for 3 years | -13.69 | 8.09 | -169% |
Returns for 5 years | 4.65 | 59.57 | 8% |
Returns for 10 years | -18.59 | 138.10 | -13% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 36.49 | 0.81 | +2.27% |
Eventide Healthcare & Life Sciences A | |||
IGREX | 9.56 | 0.11 | +1.16% |
Invesco Global Real Estate R5 | |||
EITEX | 43.30 | 0.27 | +0.63% |
Parametric Tax-Managed Emerg Mkt I | |||
HAGIX | 84.70 | 0.45 | +0.53% |
Carillon Eagle Mid Cap Growth I | |||
GEMHX | 12.79 | N/A | N/A |
Goldman Sachs Emerging Mkts Eq ex. Chn A |